158 related articles for article (PubMed ID: 18955017)
1. Prostate cancer control and survival in Vietnam veterans exposed to Agent Orange.
Everly L; Merrick GS; Allen ZA; Butler WM; Wallner K; Lief JH; Galbreath RW; Adamovich E
Brachytherapy; 2009; 8(1):57-62. PubMed ID: 18955017
[TBL] [Abstract][Full Text] [Related]
2. Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Chamie K; DeVere White RW; Lee D; Ok JH; Ellison LM
Cancer; 2008 Nov; 113(9):2464-70. PubMed ID: 18666213
[TBL] [Abstract][Full Text] [Related]
3. Prostate cancer detection in veterans with a history of Agent Orange exposure.
Zafar MB; Terris MK
J Urol; 2001 Jul; 166(1):100-3. PubMed ID: 11435832
[TBL] [Abstract][Full Text] [Related]
4. Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam.
Merrick GS; Butler WM; Wallner KE; Galbreath RW; Allen ZA; Adamovich E; Lief J
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):34-40. PubMed ID: 17289288
[TBL] [Abstract][Full Text] [Related]
5. Editorial comment on: Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.
Shah SR; Terris MK
Cancer; 2008 Nov; 113(9):2382-4. PubMed ID: 18661514
[No Abstract] [Full Text] [Related]
6. Prostate brachytherapy in men > or =75 years of age.
Merrick GS; Wallner KE; Galbreath RW; Butler WM; Brammer SG; Allen ZA; Adamovich E
Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):415-20. PubMed ID: 18374514
[TBL] [Abstract][Full Text] [Related]
7. Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer.
Merrick GS; Galbreath RW; Butler WM; Waller KE; Allen ZA; Lief J; Adamovich E
Cancer; 2007 Jul; 110(2):289-96. PubMed ID: 17549691
[TBL] [Abstract][Full Text] [Related]
8. Obesity is not predictive of overall survival following permanent prostate brachytherapy.
Merrick GS; Galbreath RW; Butler WM; Wallner KE; Allen ZA; Adamovich E
Am J Clin Oncol; 2007 Dec; 30(6):588-96. PubMed ID: 18091052
[TBL] [Abstract][Full Text] [Related]
9. Agent Orange and long-term outcomes after radical prostatectomy.
Ovadia AE; Terris MK; Aronson WJ; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ; Abern MR
Urol Oncol; 2015 Jul; 33(7):329.e1-6. PubMed ID: 25998746
[TBL] [Abstract][Full Text] [Related]
10. A critical review of the epidemiology of Agent Orange/TCDD and prostate cancer.
Chang ET; Boffetta P; Adami HO; Cole P; Mandel JS
Eur J Epidemiol; 2014 Oct; 29(10):667-723. PubMed ID: 25064616
[TBL] [Abstract][Full Text] [Related]
11. Urologic cancer risks for veterans exposed to Agent Orange.
Hoenemeyer LA
Urol Nurs; 2013; 33(2):87-90, 99. PubMed ID: 23734554
[TBL] [Abstract][Full Text] [Related]
12. Agent Orange Exposure and Monoclonal Gammopathy of Undetermined Significance: An Operation Ranch Hand Veteran Cohort Study.
Landgren O; Shim YK; Michalek J; Costello R; Burton D; Ketchum N; Calvo KR; Caporaso N; Raveche E; Middleton D; Marti G; Vogt RF
JAMA Oncol; 2015 Nov; 1(8):1061-8. PubMed ID: 26335650
[TBL] [Abstract][Full Text] [Related]
13. Agent Orange: management of patients exposed in Vietnam.
Beaulieu A; Fessele K
Clin J Oncol Nurs; 2003; 7(3):320-3. PubMed ID: 12793339
[TBL] [Abstract][Full Text] [Related]
14. Blue Water Navy Vietnam Veterans and Agent Orange Exposure.
Mil Med; 2015 Aug; 180(8):839-41. PubMed ID: 26226521
[No Abstract] [Full Text] [Related]
15. High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.
Fang LC; Merrick GS; Butler WM; Galbreath RW; Murray BC; Reed JL; Adamovich E; Wallner KE
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):992-6. PubMed ID: 20932674
[TBL] [Abstract][Full Text] [Related]
16. Agent orange exposure and prostate cancer risk in the million veteran program.
Pagadala MS; Lui AJ; Zhong AY; Lynch JA; Karunamuni R; Lee KM; Plym A; Rose BS; Carter HK; Kibel AS; DuVall SL; Gaziano JM; Panizzon MS; Hauger RL; Seibert TM
Acta Oncol; 2024 May; 63():373-378. PubMed ID: 38779869
[TBL] [Abstract][Full Text] [Related]
17. Agent Orange, prostate cancer irradiation and acute promyelocyic leukemia (APL): is there a link?
Atallah E; Schiffer CA
Leuk Res; 2007 May; 31(5):720-1. PubMed ID: 16956658
[No Abstract] [Full Text] [Related]
18. The impact of diabetes mellitus on survival in men with clinically localized prostate cancer treated with permanent interstitial brachytherapy.
Shetti MB; Merrick GS; Butler WM; Galbreath R; Torlone A; Lief JH; Adamovich E; Wallner KE
Am J Clin Oncol; 2012 Dec; 35(6):572-9. PubMed ID: 22134514
[TBL] [Abstract][Full Text] [Related]
19. Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?
Bittner N; Merrick GS; Wallner KE; Butler WM; Galbreath R; Adamovich E
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1078-84. PubMed ID: 19553031
[TBL] [Abstract][Full Text] [Related]
20. Association between Agent Orange and prostate cancer: a pilot case-control study.
Giri VN; Cassidy AE; Beebe-Dimmer J; Ellis L; Smith DC; Bock CH; Cooney KA
Urology; 2004 Apr; 63(4):757-60; discussion 760-1. PubMed ID: 15072895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
